Patent ID: 8710100

Claim:
A method of treating Crohn's disease or ulcerative rectocolitis, comprising administering to a mammal in need thereof a compound that activates a PPARγ receptor, and represented by the general formula (I) in which R 1 and R 2 , which may be identical or different, are selected from the group consisting of —H or a linear or branched alkyl group having from 1 to 6 carbon atoms; Y is selected from the group consisting of —H, —OH, —OR 3 , or —COOH wherein R 3 is selected from the group consisting of phenyl, benzyl, —CF 3 , —CF 2 CF 3 , vinyl, allyl, and a linear or branched alkyl group having from 1 to 6 carbon atoms; Z is —CH(OR 3 )COOH, in which R 3 is selected from the group consisting of H, phenyl, benzyl, —CF 3 or —CF 2 CF 3 , vinyl, allyl and a linear or branched alkyl group having from 1 to 6 carbon atoms; or salts thereof.